Hi Sussex, I see from your profile that you are type 2, so here is the lowdown on the treatment. It is fairly new, having only been approved in the UK in May 2007. It has to be injected twice a day, before breakfast and evening meal (or before lunch and evening meal provided the injections are a minimum of 6 hours apart). It works in 5 different ways, as follows:
- Byetta (Exenatide) increases insulin secretion by the pancreas in response to eating meals; the result is the release of a higher, more appropriate amount of insulin that helps lower the rise in blood sugar from eating. Once blood sugar levels decrease closer to normal values, the pancreas response to produce insulin is reduced. By comparison injected insulin is effective at lowering blood sugar, but can "overshoot" the target and cause blood sugar to become too low, resulting in hypoglycemia.
- Byetta suppresses pancreatic release of glucagon in response to eating, which helps stop the liver from overproducing sugar when it is unneeded, which prevents hyperglycemia (high blood sugar levels).
- Byetta helps slow down gastric emptying and so decreases the rate at which meal-derived glucose appears in the bloodstream.
- Byetta reduces appetite and thus may prevent weight gain. Most people using Byetta slowly lose weight, and generally the greatest weight loss is achieved by people who are the most overweight at the beginning of therapy. Clinical trials have demonstrated that the weight reducing effect continues at the same rate through 2.25 years of continued use.
- Byetta reduces liver fat content. Fat accumulation in the liver (non-alcoholic fatty liver disease or NAFLD) is strongly related with several metabolic disorders, in particular low HDL cholesterol and high triglycerides, present in patients with type 2 diabetes.
Side effects are nausea (57.1% of patients), vomiting (17.4%) and diarrhea (8.5%). For most patients, the nausea is mild to moderate and goes away entirely after a few days.
It can only be used for treatment of Type 2 diabetes and should not be used in conjunction with injected insulin (as there has been no published research on the safety of this). In the UK it cannot be used as a stand-alone medication. It has to be used as a secondary treatment, generally with metformin, or a glitazone, or a sulphonylurea as the primary treatment.
I think that covers most of it but if you have any other questions, please fire away.